Hers vs Wellorithm: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Wellorithm beats Hers overall, scoring 7.4/10 vs 7.3/10. Wellorithm is more affordable at $147/mo vs $199/mo. Choose Hers for women who want brand-name wegovy (injection or pill) at $149. Choose Wellorithm for cash-pay patients who want compounded semaglutide or tirzepa.
A side-by-side look at Hers and Wellorithm to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Hers
#34 of 53The women's health arm of Hims & Hers Health (NYSE: HIMS). In 2026 Hers signed a direct Novo Nordisk partnership adding FDA-approved Wegovy (pen and pill) at $149/mo and Zepbound via the Lilly partnership, alongside their existing compounded semaglutide and new compounded tirzepatide programs.
Visit HersWellorithm
#29 of 53Telehealth platform for compounded semaglutide and tirzepatide that uniquely offers BOTH injectable and oral dissolving tablet formats, paired with a 10% weight-loss guarantee that refunds up to four months of program fees if the patient does not lose at least 10% of baseline weight after 16 weeks of medication adherence (terms apply). 28-day recurring billing, non-refundable per-cycle, with a documented address listed in Berlin, Germany.
Visit Wellorithm| Feature | Hers | Wellorithm |
|---|---|---|
| Our Score | 7.3/10 | 7.4/10 |
| Starting Price | $199/mo | $147/mo |
| Medication Type | Both | Compounded |
| Insurance Accepted | No | No |
| Best For | Women who want brand-name Wegovy (injection or pill) at $149/mo via the 2026 Novo Nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand | Cash-pay patients who want compounded semaglutide or tirzepatide in a rare oral dissolving tablet format, backed by a 10% weight-loss money-back guarantee and 24/7 support |
| Watch out for | Membership + medication are billed separately ($39 first month / $149 ongoing membership), so total both line items before comparing prices | Founding year, corporate ownership, and named prescribers are NOT publicly disclosed, and the only address listed is a German one (Berlin, DE 81566), unusual for a platform serving US patients; if disclosed leadership matters to you, weigh this first |
| Ranking | #34 | #29 |
| Get started | Visit Hers | Visit Wellorithm |
Pros & Cons Compared
Hers
Pros
- +2026 Novo Nordisk partnership, FDA-approved Wegovy pen and Wegovy oral pill from $149/mo, one of the lowest brand-name GLP-1 prices on the market
- +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services
Cons
- −Membership + medication are billed separately ($39 first month / $149 ongoing membership), so total both line items before comparing prices
- −Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
- −Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
- −Zepbound access priced at ~$1,899/mo (brand cash) via the Lilly partnership, read as access, not value
Wellorithm
Pros
- +Compounded GLP-1 available in BOTH injectable AND oral dissolving tablet formats, semaglutide and tirzepatide each in two formats, broader format menu than most compounded-only platforms
- +10% weight-loss money-back guarantee: patients who don't lose at least 10% of baseline weight after 16 weeks of medication adherence may be eligible for refund of up to four months of program fees (verified weight documentation required)
- +Competitive entry pricing, $147/mo compounded semaglutide and $249/mo compounded tirzepatide put Wellorithm near the cheaper end of the compounded market
- +2-minute qualification quiz, virtual consultation, 24/7 support availability claimed
- +23,000+ reviews and 4.9-star rating reported (volume is unusually high for this market segment, verify on independent third-party sources before relying on it)
- +Spring promotion advertised at $147 with free shipping included
Cons
- −Founding year, corporate ownership, and named prescribers are NOT publicly disclosed, and the only address listed is a German one (Berlin, DE 81566), unusual for a platform serving US patients; if disclosed leadership matters to you, weigh this first
- −49 states only, service is unavailable in Louisiana and outside the United States
- −Billing runs on a 28-day recurring cycle and payments are non-refundable once processed, with no proration for partial months; cancel before your next cycle processes to avoid paying for an unused month
- −Compounded-only, no FDA-approved Wegovy, Zepbound, Ozempic, Mounjaro, or Foundayo; FDA does not review compounded medications for safety, effectiveness, or manufacturing quality
- −The weight-loss guarantee has strict eligibility terms: verified weight documentation (doctor attestation or video evidence), prior medication history disclosure, consistent dosing adherence, and refund processed within 30 days of approval, with only fees actually paid refundable and baseline payments non-refundable; document your starting weight from day one if you plan to rely on it
- −Two different affiliate landing pages (campaign-7 and qoroxapi/lead.php direct route) run different funnel structures, so the post-click experience can vary
Our Verdict
Wellorithm edges out Hers with a score of 7.4/10 vs 7.3/10. If budget is your priority, Wellorithm starts at $147/mo compared to Hers's $199/mo. Hers offers both brand-name and compounded medications, giving you more flexibility. Choose Hers if you want: women who want brand-name wegovy (injection or pill) at $149/mo via the 2026 novo nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand. Choose Wellorithm if you want: cash-pay patients who want compounded semaglutide or tirzepatide in a rare oral dissolving tablet format, backed by a 10% weight-loss money-back guarantee and 24/7 support.
Still undecided? Editor's Featured Pick
TrimRx
$149/mo · 7.8/10 · Compounded
If neither Hers nor Wellorithm feels like the right fit, our featured pick across all 53 GLP-1 telehealth providers is TrimRx. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $149/mo that stays the same at every dose.
Read Full Reviews
Related comparisons
Other matchups readers comparing Hers or Wellorithm tend to look at next.
- Hers vs Sprout Health$199/mo
- Hers vs Enhance MD$212/mo
- Hers vs MEDVi$179/mo
- Wellorithm vs TrimRx$149/mo
- Wellorithm vs Strut Health$149/mo
- Wellorithm vs Maximus$150/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.